Great West Life Assurance CO Iovance Biotherapeutics, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 57,265 shares of IOVA stock, worth $205,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,265
Previous 60,749
5.74%
Holding current value
$205,581
Previous $571,000
25.74%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$98.8 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$87.7 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$79.4 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$76.2 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$44 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $567M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...